Lifecore Biomedical (LDE) Stock Forecast & Price Target
LDE Analyst Ratings
Hold
0Buy4Hold0Sell
Based on 4 analysts giving stock ratings to Lifecore Biomedical in the past 3 months
LDE Stock 12 Month Forecast
Average Price Target
EUR 5.65▼(-0.96% Downside)Based on 4 Wall Street analysts offering 12 month price targets for Lifecore Biomedical in the last 3 months. The average price target is EUR 5.65 with a high forecast of EUR 5.65 and a low forecast of EUR 5.65. The average price target represents a -0.96% change from the last price of EUR 5.70.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 5.65
AverageEUR 5.65
LowEUR 5.65
Highest Price TargetHighestEUR 5.65Average Price TargetEUR 5.65Lowest Price TargetLowestEUR 5.65
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jared Haase | William Blair | ― | hold | ― | Downgraded | 10/03/26 | ||
| Michael Petusky | Barrington | ― | hold | ― | Downgraded | 10/01/26 | ||
| Matt Hewitt | Craig-Hallum | EUR 5.65 | hold | -0.96%Downside | Downgraded | 09/29/26 | ||
| Paul Knight | KeyBanc | ― | hold | ― | Reiterated | 08/06/26 | ||
| Steven Etoch | Stephens | EUR 7.64→EUR 4.49 | hold | -21.15%Downside | Reiterated | 03/17/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jared Haase | 10/03/26 | ― | hold | ― | Downgraded | William Blair | ||
| Michael Petusky | 10/01/26 | ― | hold | ― | Downgraded | Barrington | ||
| Matt Hewitt | 09/29/26 | EUR 5.65 | hold | -0.96%Downside | Downgraded | Craig-Hallum | ||
| Paul Knight | 08/06/26 | ― | hold | ― | Reiterated | KeyBanc | ||
| Steven Etoch | 03/17/26 | EUR 7.64→EUR 4.49 | hold | -21.15%Downside | Reiterated | Stephens |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
LDE Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 |
| Buy | 6 | 6 | 7 | 5 | 4 |
| Hold | 0 | 0 | 1 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 7 | 8 | 8 | 9 |
In the current month, LDE has received 4 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. LDE average Analyst price target in the past 3 months is 5.65.
LDE Financial Forecast
ConsensusEUR 0.00
LDE Sales Forecast
Next quarter’s sales forecast for LDE is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 30.59M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
LDE Stock Forecast FAQ
What is DE:LDE’s average 12-month price target, according to analysts?
Based on analyst ratings, Lifecore Biomedical’s 12-month average price target is €5.65.
What is DE:LDE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:LDE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Lifecore Biomedical a Buy, Sell or Hold?
Lifecore Biomedical has a consensus rating of Hold, which is based on 0 buy ratings, 4 hold ratings and 0 sell ratings.
What is Lifecore Biomedical’s share price target?
The average share price target for Lifecore Biomedical is €5.65. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €5.65, and the lowest forecast is €5.65. The average share price target represents a 0.96% decrease from the current price of €5.7.
What do analysts say about Lifecore Biomedical?
Lifecore Biomedical’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Lifecore Biomedical?
To buy shares of DE:LDE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
